Controlled Study of Upper and Lower Limb Movements in Patients Patients with Pathologies That Have an Impact on Ambulation or Motor Function
Launched by LAURENT SERVAIS · May 31, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different movements of the arms and legs can be measured and analyzed in people with neurological conditions, such as neuromuscular diseases. The researchers want to improve the technology that tracks these movements by using special sensors. This could help doctors understand how well patients can move and identify issues related to their conditions.
To participate in the study, individuals must be over 2 years old. They can either be healthy individuals with no movement problems or patients diagnosed with a neurological condition that affects their movement. Participants will need to provide written consent, and if they are minors, a parent or guardian must sign on their behalf. The study is currently recruiting participants, so if someone joins, they can expect to help advance our understanding of movement disorders and potentially improve future treatments. It's important to note that people with certain previous injuries or conditions may not be eligible, and pregnant or breastfeeding women cannot participate.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Subjects over 2 years old
- • Male or female
- • Control subjects with no pathologies that have an impact on ambulation or motor function.
- • Signed informed consent and, in the case of minors, informed consent signed by the person with parental authority/guardian
- Exclusion Criteria:
- • Any other previous or present pathology having an impact on current motor or balance function
- • Recent surgery or trauma to upper or lower limbs, or major surgery or trauma within 6 months of inclusion.
- • For control subjects, athlete of at least national level.
- • Pregnant or breast-feeding women
About Laurent Servais
Laurent Servais is a prominent clinical trial sponsor dedicated to advancing medical research through innovative and rigorous study designs. With a focus on neuromuscular disorders, the organization collaborates with leading researchers and institutions to develop effective therapies that improve patient outcomes. Committed to ethical standards and regulatory compliance, Laurent Servais prioritizes transparency and patient safety in all clinical endeavors, fostering an environment of collaboration and scientific excellence. Through its strategic initiatives, the sponsor aims to contribute significantly to the understanding and treatment of rare diseases, ultimately enhancing the quality of life for affected individuals.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Liège, Liege, Belgium
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported